142 related articles for article (PubMed ID: 17987220)
1. Darunavir.
El-Atrouni WI; Temesgen Z
Drugs Today (Barc); 2007 Oct; 43(10):671-9. PubMed ID: 17987220
[TBL] [Abstract][Full Text] [Related]
2. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
Lefebvre E; Schiffer CA
AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
[TBL] [Abstract][Full Text] [Related]
3. New therapeutic agents in the management of HIV: an overview of darunavir for clinicians.
Rotty J; Hoy J
Sex Health; 2008 Sep; 5(3):235-41. PubMed ID: 18771638
[TBL] [Abstract][Full Text] [Related]
4. Darunavir (TMC114): a new HIV-1 protease inhibitor.
Molina JM; Hill A
Expert Opin Pharmacother; 2007 Aug; 8(12):1951-64. PubMed ID: 17696796
[TBL] [Abstract][Full Text] [Related]
5. Darunavir: a nonpeptidic antiretroviral protease inhibitor.
McCoy C
Clin Ther; 2007 Aug; 29(8):1559-76. PubMed ID: 17919539
[TBL] [Abstract][Full Text] [Related]
6. Darunavir: an overview of an HIV protease inhibitor developed to overcome drug resistance.
Taiwo BO; Hicks CB
AIDS Read; 2007 Mar; 17(3):151-6, 159-61. PubMed ID: 17396332
[TBL] [Abstract][Full Text] [Related]
7. Darunavir : a nonpeptidic protease inhibitor for antiretroviral-naive and treatment-experienced adults with HIV infection.
Robertson J; Feinberg J
Expert Opin Pharmacother; 2012 Jun; 13(9):1363-75. PubMed ID: 22594781
[TBL] [Abstract][Full Text] [Related]
8. [Position of darunavir in antiretroviral therapy].
Clotet B
Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 10():61-2. PubMed ID: 19195461
[No Abstract] [Full Text] [Related]
9. Darunavir: a second-generation protease inhibitor.
Busse KH; Penzak SR
Am J Health Syst Pharm; 2007 Aug; 64(15):1593-602. PubMed ID: 17646561
[TBL] [Abstract][Full Text] [Related]
10. New protease inhibitors and non-nucleoside reverse transcriptase inhibitors.
Lascar M; Cartledge JD
J HIV Ther; 2008 Jun; 13(2):40-4. PubMed ID: 18953273
[No Abstract] [Full Text] [Related]
11. Darunavir: in treatment-experienced pediatric patients with HIV-1 infection.
McKeage K; Scott LJ
Paediatr Drugs; 2010 Apr; 12(2):123-31. PubMed ID: 20218748
[TBL] [Abstract][Full Text] [Related]
12. Darunavir: a critical review of its properties, use and drug interactions.
Ruela Corrêa JC; D'Arcy DM; dos Reis Serra CH; Nunes Salgado HR
Pharmacology; 2012; 90(1-2):102-9. PubMed ID: 22797653
[TBL] [Abstract][Full Text] [Related]
13. Darunavir in the treatment of HIV-1 infection: a viewpoint by Mark Holodniy.
Holodniy M
Drugs; 2007; 67(18):2803. PubMed ID: 18062725
[No Abstract] [Full Text] [Related]
14. [Chemical characteristics, mechanism of action and antiviral activity of darunavir].
Pasquau Liaño J; Hidalgo Tenorio C
Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 10():3-9. PubMed ID: 19195453
[TBL] [Abstract][Full Text] [Related]
15. Anti-HIV agents. Darunavir shows its strength.
TreatmentUpdate; 2007; 19(5):2-4. PubMed ID: 17955613
[No Abstract] [Full Text] [Related]
16. Darunavir in the treatment of HIV-1 infection: a viewpoint by Renslow Sherer.
Sherer R
Drugs; 2007; 67(18):2802-3. PubMed ID: 18062726
[No Abstract] [Full Text] [Related]
17. Effect of baseline viral susceptibility on response to darunavir/ritonavir versus control protease inhibitors in treatment-experienced HIV type 1-infected patients: POWER 1 and 2.
Pozniak A; Opravil M; Beatty G; Hill A; de Béthune MP; Lefebvre E
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1275-80. PubMed ID: 18844462
[TBL] [Abstract][Full Text] [Related]
18. Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine).
Arribas JR
Curr Opin HIV AIDS; 2009 Nov; 4(6):507-12. PubMed ID: 20048718
[TBL] [Abstract][Full Text] [Related]
19. [Preserving future therapy options. Darunavir--the protease inhibitor for various patient groups].
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():24-5. PubMed ID: 19024912
[No Abstract] [Full Text] [Related]
20. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
